Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.
Deciphex has raised $32.2M in total funding. The most recent round was Series C. The last funding was announced in January 2025.
Deciphex's investors include Novartis, Enterprise Ireland, GI Partners, Claret Capital Partners, Charles River Laboratories International.
Deciphex is headquartered in Glasnevin, Ireland.
Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.
Deciphex is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Deciphex — Funding & Investors." VCBacked, January 7, 2025, https://www.vcbacked.co/company/deciphex. Accessed July 19, 2026.
VCBacked. (2025). Deciphex — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/deciphex
{{cite web |title=Deciphex — Funding & Investors |url=https://www.vcbacked.co/company/deciphex |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated